PHGE - BiomX Inc Market Cap to Sales Volume

BiomX Inc. is establishing secure bio-raw material supply chains and cold-chain logistics for the distribution of phage preparations. Its proprietary therapy for resistant infections lays the foundation for the monetization of intellectual property. However, the lack of operating cash flow leaves the company dependent on grants. The price-to-sales multiple on this chart demonstrates the valuation trend, where the indicator reached the level of 7.10.

The P/S multiple compares the market value of BiomX Inc. (PHGE) to its annual revenue, reflecting the market valuation of every dollar of sales. A decrease in this value indicates that the asset is undervalued, while an increase signals inflated investor expectations. By analyzing the current P/S ratio, one can track the business valuation dynamics between reporting periods. A high valuation is justified by the implementation of robotic screening, which exponentially accelerates the search for bacteriophages.